Clindamycin - CAS 18323-44-9

Clindamycin inhibits protein synthesis by acting on the 50S ribosomal, used for the treatment of bacterial infections.

Clindamycin is a semisynthetic analogue of lincomycin. Clindamycin primarily inhibits the initiation of peptide chain synthesis by deregulating enzyme-catalyzed initiation of peptide bounds. Clindamycin appears to have a modest effect on protein synthesis by certain mammalian cells.

Clindamycin (50mg/kg daily administrated by intramuscular) increases the survival rate of monkeys infected with penicillin-resistant S. aureu to 87.5% (7/8).

Catalog Number: A000300

CAS Number: 18323-44-9

PubChem Substance ID:385373148

Molecular Formula: C18H33ClN2O5S

Molecular Weight:425.0

Purity: 98.0%

Appearance:A crystalline solid

* For research use only. Not for human or veterinary use.

Synonym

• Synonyms: NA

Property

• Molecular Formula: C18H33ClN2O5S
• Molecular Weight: 425.0
• Purity: 98.0%
• Storage: 3 years -20C powder

Computed Descriptor

• InChIKey: KDLRVYVGXIQJDK-AWPVFWJPSA-N